Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

579
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
579
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

215
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
215
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

306
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
306
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

635
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
635
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

751
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
751
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

153
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
153

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antibacterial and Antibiofilm Potential of Thymol-Benzimidazolium-Chalcone Hybrids Against Clinical MRSA Strains: Insights from Gene Expression Profiling and Molecular Docking.

Antibiotics (Basel, Switzerland)·2026
Same author

Changes in Optic Nerve Sheath Diameter With Lateral Decubitus Positioning and Pneumoperitoneum Pressure During Laparoscopic Partial Nephrectomy.

International journal of urology : official journal of the Japanese Urological Association·2026
Same author

Nephroprotective effects of visnagin through modulation of macrophage polarization, oxidative stress, inflammation and apoptosis in renal I/R injury.

Open medicine (Warsaw, Poland)·2026
Same author

Comparison of dynamic thiol/disulfide homeostasis in percutaneous nephrolithotomy and retrograde intrarenal surgery.

Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica·2025
Same author

Evaluating shear wave elastography as a predictor of extracorporeal shock wave lithotripsy outcomes in children.

Urolithiasis·2025
Same author

A pioneer Turkish urologist-medical historian (Saim Erkun 1901-1949) and his one-century-old review about prostate.

Journal of medical biography·2024

Related Experiment Video

Updated: Sep 25, 2025

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

275

Relationship between erectile dysfunction and Helicobacter pylori: A prospective controlled pilot study.

Ismail Yağmur1, Mehmet Demir1, Halil Çiftçi1

  • 1Department of Urology, Harran University, Sanliurfa, Turkey.

Andrologia
|April 25, 2022
PubMed
Summary

Helicobacter pylori (Hp) infection is linked to arteriogenic erectile dysfunction (ED). Hp-specific IgG and C-reactive protein (CRP) levels were significantly higher in ED patients, suggesting Hp seropositivity as a potential ED diagnostic marker.

Keywords:
C-reactive proteinHelicobacter pyloriatherosclerosiserectile dysfunction

More Related Videos

Retinal and Choroidal Thickness Changes in Populations with Helicobacter pylori Infection by Swept-Source Optical Coherence Tomography
03:47

Retinal and Choroidal Thickness Changes in Populations with Helicobacter pylori Infection by Swept-Source Optical Coherence Tomography

Published on: November 1, 2024

285
Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
05:23

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance

Published on: March 7, 2025

509

Related Experiment Videos

Last Updated: Sep 25, 2025

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

275
Retinal and Choroidal Thickness Changes in Populations with Helicobacter pylori Infection by Swept-Source Optical Coherence Tomography
03:47

Retinal and Choroidal Thickness Changes in Populations with Helicobacter pylori Infection by Swept-Source Optical Coherence Tomography

Published on: November 1, 2024

285
Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
05:23

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance

Published on: March 7, 2025

509

Area of Science:

  • Urology
  • Gastroenterology
  • Infectious Diseases

Background:

  • Erectile dysfunction (ED) significantly impacts quality of life.
  • Arteriogenic ED, caused by penile arterial insufficiency, is a common form of ED.
  • Helicobacter pylori (Hp) infection is a widespread bacterial infection with potential systemic effects.

Purpose of the Study:

  • To investigate the correlation between Helicobacter pylori (Hp) infection and arteriogenic erectile dysfunction (ED).
  • To explore Hp seropositivity as a potential auxiliary diagnostic marker for ED.

Main Methods:

  • A case-control study involving 30 patients with arteriogenic ED and 30 healthy controls.
  • Measurement of Hp-specific Immunoglobulin G (IgG) antibody levels using Enzyme-linked immunosorbent assay (ELISA).
  • Assessment of C-reactive protein (CRP) levels, fasting blood glucose, and serum lipid profiles.

Main Results:

  • Patients with ED exhibited significantly higher levels of Hp-specific IgG antibodies compared to controls (39.7 ± 23.2 vs. 21.0 ± 19.8 arbU/ml, p=0.001).
  • Mean CRP levels were also significantly elevated in the ED group (0.3 ± 0.2 vs. 0.1 ± 0.1 mg/dl, p=0.01).
  • A positive correlation was observed between ED, Hp-specific IgG levels, and CRP.

Conclusions:

  • Preliminary findings suggest a potential association between Helicobacter pylori infection and arteriogenic erectile dysfunction.
  • Hp seropositivity may serve as an auxiliary marker in the diagnostic workup for ED.
  • Further research is warranted to confirm these findings and explore the clinical benefits of Hp eradication in ED management.